Dr. Paul R. Kahn, MD

Dr. Kahn practices at Uro-Surg Associates in Cape Coral, Florida.

Dr. Kahn's NPI, 1538367016, was assigned on July 6, 2007. Dr. Kahn graduated from University of the West Indies Faculty of Medical Sciences in 1977. Dr. Kahn holds Florida license ME37234.

Dr. Kahn's primary practice is Uro-Surg Associates, at 1419 SE 8th Ter, Cape Coral, FL 33990 in Lee County. The practice phone is (954) 474-2929.

Dr. Kahn's primary practice is Uro-Surg Associates in Cape Coral, Florida. Dr. Kahn is also affiliated with HCA Florida Westside Hospital. The medical group on file is GenesisCare. Dmand AI also links Dr. Kahn to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahn practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kahn's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kahn is licensed in Florida.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Kahn treats.

CMS data shows 43,480 Medicare services from Dr. Kahn across 23 procedure codes in 2024, for 807 Medicare patients. Medicare paid $334,698 for them. Every service was in an office.

CMS counts 807 Medicare patients who saw Dr. Kahn in 2024. The largest group is 65 to 74, with 366 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kahn's median patient age at 70, with 14% women.

In 2024, Dr. Kahn wrote 1,951 Medicare Part D claims for 766 patients. 85% of them were for generic drugs. CMS names the drug for 1,799 of them, across 25 drugs with 11 or more claims each, at $1,071,444 in total drug cost. In 2023, CMS named 2,162 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Kahn for performance year 2024, reported individually. Dr. Kahn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Kahn. The most frequent topics are Urinary Bladder Neoplasms. Dr. Kahn has published most often in J Urol. Dr. Kahn's most frequent co-authors are Julia A. Bridge, MD, Jorge L. Lockhart, MD and Julio M. Pow-Sang, MD.

CMS Open Payments shows 581 general payments to Dr. Kahn from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Astellas Pharma US Inc paid the most, $1,615.

Dmand AI lists 4 awards for Dr. Kahn, most recently Gulfstream FL-Broward in 2013.

Dr. Kahn graduated from University of the West Indies Faculty of Medical Sciences in 1977. Dr. Kahn is a member of ACS.

Dr. Kahn is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.